The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1154
ISSUE1154
April 14, 2003
Nitazoxanide (Alinia) -- a New Anti-protozoal Agent
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Nitazoxanide (Alinia) -- a New Anti-protozoal Agent
April 14, 2003 (Issue: 1154)
Nitazoxanide (Alinia - Romark Labs), a new antiparasitic drug, has been approved by the FDA in a liquid formulation for treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia in children 1 to 11 years old. It is the first drug...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.